Adage Capital Partners Gp, L.L.C. United Therapeutics Corp Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $14.4 Million - $16.3 Million	-70,000 Reduced 58.33%	50,000 $11 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $18.5 Million - $24 Million	-87,000 Reduced 42.03%	120,000 $26.9 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $30.5 Million - $41.5 Million	-148,000 Reduced 41.69%	207,000 $57.6 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $28.5 Million - $34.2 Million	140,000 Added 65.12%	355,000 $74.3 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $14.9 Million - $20.5 Million	-85,000 Reduced 28.33%	215,000 $50.7 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $16.6 Million - $21.4 Million	-100,000 Reduced 25.0%	300,000 $53.8 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $18 Million - $21.5 Million	-100,000 Reduced 20.0%	400,000 $73.8 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $12.8 Million - $15.9 Million	75,000 Added 17.65%	500,000 $89.7 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $61.6 Million - $69.9 Million	-400,000 Reduced 48.48%	425,000 $71.1 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $35.7 Million - $53.1 Million	-350,000 Reduced 29.79%	825,000 $125 Million
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $7.49 Million - $9.08 Million	75,000 Added 6.82%	1,175,000 $119 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $17.3 Million - $23.5 Million	-186,622 Reduced 14.5%	1,100,000 $133 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $42.6 Million - $61.9 Million	536,622 Added 71.55%	1,286,622 $122 Million
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $39.2 Million - $47.7 Million	500,000 Added 200.0%	750,000 $66.1 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $7.48 Million - $8.6 Million	100,000 Added 66.67%	250,000 $19.9 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $11.4 Million - $18.1 Million	150,000 New	150,000 $11.7 Million

Others Institutions Holding UTHR

# of Institutions

673

Shares Held

42.2M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$2 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.61 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.16 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.04 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$817 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account